What Are Bacterial Meningitis Vaccinations?

Q:
What are bacterial meningitis vaccinations?

A:
Of the 1,000-2,600 people who get meningococcal disease each year, one-third are teens and young adults. Ten percent to 15% of those who get sick with the disease will die, even with antibiotic treatment. As many as 20% will have permanent side effects, such as hearing loss or brain damage.

The immunization can help prevent this serious disease.

In the U.S., three meningococcal vaccines are available:

  • Meningococcal polysaccharide vaccine (MPSV4), sold as Menomune
  • Meningococcal conjugate vaccine (MCV4), sold as Menactra, MenHibrix, and Menveo.
  • Serogroup B meningococcal vaccine, sold as Trumenba and Bexsero.

The CDC recommends a meningococcal vaccine for:

  • All children ages 11-18 or certain younger high-risk children
  • Anyone who has been exposed to meningitis during an outbreak
  • Anyone traveling to or living where meningitis is common, such as in sub-Saharan Africa
  • Military recruits
  • People with certain immune system disorders or a damaged or missing spleen

Your preteen or teen shouldn’t get the meningococcal vaccine if he or she:

  • Has ever had Guillain-Barre syndrome
  • Is moderately or severely ill (reschedule when you are well)
  • Has had a severe, life-threatening allergic reaction to a meningococcal vaccine before or to any vaccine component

Keyword: bacterial meningitis vaccination; bacterial meningitis vaccinations; bacterial meningitis vaccine

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.